title: Debrisoquine oxidation in schizophrenic patients treated with neuroleptics.
authors.affiliation: Institute of Pharmacology, University of Messina, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Spina
authors.forename: A L
authors.initials: AL
authors.lastname: Buemi
authors.forename: A P
authors.initials: AP
authors.lastname: Caputi
authors.forename: J
authors.initials: J
authors.lastname: Benitez
authors.forename: J
authors.initials: J
authors.lastname: Cobaleda
authors.forename: M A
authors.initials: MA
authors.lastname: Garcia
authors.forename: A
authors.initials: A
authors.lastname: Llerena
authors.forename: B
authors.initials: B
authors.lastname: Piña
mesh_terms: D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002746:Chlorpromazine / Q000494:pharmacology; D003647:Debrisoquin / Q000031:analogs & derivatives / Q000097:blood / Q000378:metabolism*; D005260:Female; D006801:Humans; D006900:Hydroxylation; D007546:Isoquinolines / Q000378:metabolism*; D008297:Male; D008728:Methotrimeprazine / Q000494:pharmacology; D008875:Middle Aged; D010084:Oxidation-Reduction; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism*; D013881:Thioridazine / Q000494:pharmacology
chemical_list: D014150:Antipsychotic Agents; D007546:Isoquinolines; C012359:4-hydroxydebrisoquin; D008728:Methotrimeprazine; D013881:Thioridazine; D002746:Chlorpromazine; D003647:Debrisoquin